Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Evolus, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +19 vs. Q1 2021
- Shares held
- 16.2M
- +7.62M (+88.5%) vs. Q1 2021
- Total value
- $205.3M
- +$93.5M (+83.6%) vs. Q1 2021
- New holders
- 28
- 48 more added
- Sold out
- 9
- 24 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EOLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 158 | $335.1M |
| Q1 2026 | 147 | $188.3M |
| Q4 2025 | 169 | $327.3M |
| Q3 2025 | 160 | $334.4M |
| Q2 2025 | 172 | $538.8M |
| Q1 2025 | 179 | $652.9M |
| Q4 2024 | 164 | $573.1M |
| Q3 2024 | 165 | $814.5M |
| Q2 2024 | 156 | $557.1M |
| Q1 2024 | 164 | $691.0M |
| Q4 2023 | 151 | $479.6M |
| Q3 2023 | 137 | $378.8M |
| Q2 2023 | 135 | $271.1M |
| Q1 2023 | 126 | $288.7M |
| Q4 2022 | 120 | $219.8M |
| Q3 2022 | 130 | $205.7M |
| Q2 2022 | 123 | $294.2M |
| Q1 2022 | 118 | $266.3M |
| Q4 2021 | 104 | $133.1M |
| Q3 2021 | 113 | $134.9M |
| Q2 2021 | 115 | $205.3M |
| Q1 2021 | 96 | $111.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Evolus, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SG Americas Securities, LLC | 351,813 | $4.45M | 0.02% | +255,670+265.9% | Added |
| Marshall Wace North America L.P. | 370,040 | $4.68M | 0.02% | +335,394+968.1% | Added |
| Schonfeld Strategic Advisors LLC | 394,214 | $4.99M | 0.06% | +394,214 | New |
| Marshall Wace, LLP | 488,419 | $6.18M | 0.03% | +220,296+82.2% | Added |
| Tri Locum Partners LP | 496,826 | $6.29M | 2.63% | +415,801+513.2% | Added |
| D. E. Shaw & Co., Inc. | 500,366 | $6.33M | 0.01% | +337,068+206.4% | Added |
| AWH Capital, L.P. | 515,000 | $6.51M | 5.94% | +105,000+25.6% | Added |
| State Street Corp | 537,240 | $6.80M | 0.00% | +141,825+35.9% | Added |
| Geode Capital Management, LLC | 567,609 | $7.18M | 0.00% | +184,502+48.2% | Added |
| Soleus Capital Management, L.P. | 580,000 | $7.34M | 1.13% | +580,000 | New |
| Nuveen Asset Management, LLC | 601,362 | $7.61M | 0.00% | +526,591+704.3% | Added |
| Schroder Investment Management Group | 1,359,329 | $17.2M | 0.02% | +463,730+51.8% | Added |
| First Manhattan Co | 1,383,000 | $17.5M | 0.06% | +1,383,000 | New |
| Vanguard Group Inc | 1,677,083 | $21.2M | 0.00% | +547,576+48.5% | Added |
| BlackRock Inc. | 2,127,366 | $26.9M | 0.00% | +446,255+26.5% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −79,600−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| Bender Robert & Associates | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Clarkston Capital Partners, LLC | 0 | $0 | 0.00% | −10,170−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −3,692−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,122−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |